Academic Journal
Harm-Reduction Programs and Interventions for Equity-Deserving Populations Who Use Crack-Cocaine: A Scoping Review.
| Τίτλος: | Harm-Reduction Programs and Interventions for Equity-Deserving Populations Who Use Crack-Cocaine: A Scoping Review. |
|---|---|
| Συγγραφείς: | Sculco C; Università dell Svizzera Italiana, Institute of Public Health, Lugano, Switzerland, camilla.sculco@usi.ch.; Swiss School of Public Health, Zurich, Switzerland, camilla.sculco@usi.ch.; Addiction Suisse, Lausanne, Switzerland, camilla.sculco@usi.ch., Zobel F; Addiction Suisse, Lausanne, Switzerland., Tognolini M; Addiction Suisse, Lausanne, Switzerland., Rosselet Amoussou J; Medical Library-Cery, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland., Albanese E; Università dell Svizzera Italiana, Institute of Public Health, Lugano, Switzerland., Khazaal Y; Addiction Medicine Service, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. |
| Πηγή: | European addiction research [Eur Addict Res] 2026; Vol. 32 (2), pp. 86-104. Date of Electronic Publication: 2026 Apr 07. |
| Τύπος έκδοσης: | Journal Article; Scoping Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Karger Country of Publication: Switzerland NLM ID: 9502920 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9891 (Electronic) Linking ISSN: 10226877 NLM ISO Abbreviation: Eur Addict Res Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Basel ; New York : Karger, c1995- |
| Ιατρικοί όροι (MeSH): | Cocaine-Related Disorders*/therapy , Cocaine-Related Disorders*/epidemiology , Crack Cocaine*/adverse effects , Harm Reduction*, Humans ; Diversity, Equity, Inclusion |
| Περίληψη: | <p>Background: Crack-cocaine use is associated with severe physical and mental health consequences, including cardiac, pulmonary, and psychiatric conditions. It also heightens the risk of overdose and transmission of infectious diseases such as HIV, tuberculosis, and hepatitis. Equity-deserving populations - more specifically, groups affected by socioeconomic marginalization, discrimination, and systemic inequities - are disproportionately impacted. In recent years, its rising prevalence in European cities has underscored crack-cocaine as a growing social and public health concern. This trend highlights the need to reorient drug policies toward a public health-oriented approach and to implement coherent and inclusive harm-reduction programs and interventions for equity-deserving populations. Summary: We conducted a comprehensive review of harm-reduction programs and interventions for crack-cocaine use, focusing on equity-deserving groups. A literature search was conducted in November 2024, in 9 bibliographic databases. Additional searches were performed using backward citation tracking. A total of 24 publications were included in the final dataset and underwent data extraction, synthesis, and tabulation. Extracted data informed a narrative synthesis by study and population characteristics. Key Messages: Harm-reduction programs and interventions are tailored to women who smoke crack, hospitalized patients, people living with HIV, aboriginal descendants, and marginalized urban populations. They aim to reduce crack-cocaine related mortality and morbidity, by promoting safer consumption practices and healthier lifestyles. They improve living conditions, access to employment, and community engagement. Findings advocate prioritization of harm-reduction services that attend to women's specific experiences of gendered, race-based, social and structural violence, harassment, and discrimination. Besides, despite their vulnerability, street-involved youth, migrants, and refugees are underrepresented in research, underscoring the need for inclusive programs and interventions that consider both age and migration contexts. Most research was conducted in North America, with limited studies from Latin America, Europe, and rural settings, highlighting geographic and contextual gaps. Effective harm reduction must prioritize health equity, addressing stigma, gendered and racial violence, and structural barriers to care. </p>. (© 2026 The Author(s). Published by S. Karger AG, Basel.) |
| References: | JAMA Netw Open. 2024 Oct 1;7(10):e2437241. (PMID: 39412813) Harm Reduct J. 2016 Jun 08;13(1):19. (PMID: 27278459) Qual Health Res. 2013 Apr;23(4):450-62. (PMID: 23258112) Curr Opin HIV AIDS. 2019 Sep;14(5):409-414. (PMID: 31219890) Qual Health Res. 2013 Aug;23(8):1016-26. (PMID: 23761930) Harm Reduct J. 2024 Jan 13;21(1):9. (PMID: 38218849) Harm Reduct J. 2022 Feb 4;19(1):10. (PMID: 35120539) Harm Reduct J. 2021 Mar 7;18(1):29. (PMID: 33678163) Int J Drug Policy. 2015 Dec;26(12):1177-82. (PMID: 26500166) Int J Drug Policy. 2011 Jul;22(4):292-300. (PMID: 21700443) Sci Total Environ. 2022 Nov 15;847:157222. (PMID: 35901880) Drug Alcohol Depend. 2025 Jan 1;266:112501. (PMID: 39608288) Epidemiol Rev. 2004;26:36-52. (PMID: 15234946) Health Educ J. 2024 Aug;83(5):544-559. (PMID: 40343049) Harm Reduct J. 2022 May 12;19(1):44. (PMID: 35550157) Addict Behav. 2019 Nov;98:106037. (PMID: 31330467) Lancet Psychiatry. 2016 Mar;3(3):280-96. (PMID: 26905481) Public Health Rep. 2002;117 Suppl 1:S88-95. (PMID: 12435832) Subst Abuse. 2023 Nov 9;17:11782218231208980. (PMID: 37954218) J Rural Health. 2016 Winter;32(1):92-101. (PMID: 26184098) Soc Sci Med. 2005 Sep;61(5):1026-44. (PMID: 15955404) Subst Use Misuse. 2025;60(13):2063-2069. (PMID: 40679906) Public Health Rep. 2025 Jan-Feb;140(1):40-47. (PMID: 38910545) BMC Public Health. 2017 Feb 3;17(1):163. (PMID: 28158995) Lancet Public Health. 2026 Jan;11(1):e61-e68. (PMID: 41500743) Int J Drug Policy. 2008 Aug;19(4):339-41. (PMID: 18638705) J Prev Interv Community. 2010;38(2):118-31. (PMID: 20391059) Soc Sci Med. 2019 Aug;234:112384. (PMID: 31254965) Harm Reduct J. 2025 Jan 23;22(1):11. (PMID: 39849487) Health Policy Open. 2020 Oct 06;1:100016. (PMID: 37383316) Harm Reduct J. 2023 Jul 31;20(1):101. (PMID: 37525168) Harm Reduct J. 2017 Dec 22;14(1):79. (PMID: 29273031) Subst Use Misuse. 2019;54(4):592-600. (PMID: 30654689) Subst Use Misuse. 2014 Jun;49(7):891-901. (PMID: 24611820) Harm Reduct J. 2022 Feb 9;19(1):14. (PMID: 35139877) Am J Drug Alcohol Abuse. 2015;41(5):449-57. (PMID: 26337202) BMC Health Serv Res. 2024 Nov 22;24(1):1450. (PMID: 39578888) Int J Drug Policy. 2015 Apr;26(4):352-63. (PMID: 25662894) Int J Drug Policy. 2008 Dec;19(6):492-5. (PMID: 18375110) Lancet Reg Health Am. 2022 May 11;12:100271. (PMID: 36776426) Drug Alcohol Depend. 2010 Jun 1;109(1-3):205-12. (PMID: 20219294) Syst Rev. 2022 Aug 17;11(1):172. (PMID: 35978441) JBI Evid Synth. 2021 Jun 16;19(8):1760-1843. (PMID: 34137739) Am J Public Health. 2018 Oct;108(10):1363-1365. (PMID: 30138074) J Prev (2022). 2025 Jun;46(3):427-454. (PMID: 40113659) Am J Public Health. 2018 Feb;108(2):182-186. (PMID: 29267060) AIDS Care. 2013;25(6):732-7. (PMID: 23216297) Harm Reduct J. 2025 Jun 5;22(1):96. (PMID: 40474185) AIDS Educ Prev. 2003 Feb;15(1):15-32. (PMID: 12627741) Harm Reduct J. 2021 Jan 25;18(1):13. (PMID: 33494726) |
| Contributed Indexing: | Keywords: Crack-cocaine; Drug policy; Equity-deserving populations; Harm reduction |
| Substance Nomenclature: | 0 (Crack Cocaine) |
| Entry Date(s): | Date Created: 20260407 Date Completed: 20260709 Latest Revision: 20260922 |
| Update Code: | 20260922 |
| PubMed Central ID: | PMC13271685 |
| DOI: | 10.1159/000551848 |
| PMID: | 41945484 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1421-9891 |
|---|---|
| DOI: | 10.1159/000551848 |